Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dobrila D Rudnicki

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Reviews in Molecular Medicine|October 31, 2003
Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversyDobrila D Rudnicki, Russell L Margolis
Current Opinion in Neurology|November 3, 2016
Pathogenic insights from Huntington's disease-like 2 and other Huntington's disease genocopiesRussell L Margolis, Dobrila D Rudnicki
Acta Neurologica Taiwanica|April 20, 2005
Huntington's disease like-2: review and updateRussell L Margolis, Dobrila D Rudnicki, Susan E Holmes
Human Molecular Genetics|June 16, 2011
A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expressionDaniel W Chung, Dobrila D Rudnicki, Lan Yu, et al.
Frontiers in Robotics and AI|January 27, 2021
Exploring Novel Biologically-Relevant Chemical Space Through Artificial Intelligence: The NCATS ASPIRE ProgramKatharine K Duncan, Dobrila D Rudnicki, Christopher P Austin, et al.
Journal of Neuropathology and Experimental Neurology|April 2, 2008
A comparison of huntington disease and huntington disease-like 2 neuropathologyDobrila D Rudnicki, Olga Pletnikova, Jean-Paul G Vonsattel, et al.
Annals of Neurology|March 28, 2007
Huntington's disease--like 2 is associated with CUG repeat-containing RNA fociDobrila D Rudnicki, Susan E Holmes, Mark W Lin, et al.
Disease Models & Mechanisms|February 4, 2016
Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and DrosophilaQian Zhang, Ho Tsoi, Shaohong Peng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 12, 2017
Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's DiseaseDavid G Anderson, Sergio Carmona, Kubendran Naidoo, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Reviews in Molecular Medicine|October 31, 2003
Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversyDobrila D Rudnicki, Russell L Margolis
Current Opinion in Neurology|November 3, 2016
Pathogenic insights from Huntington's disease-like 2 and other Huntington's disease genocopiesRussell L Margolis, Dobrila D Rudnicki
Acta Neurologica Taiwanica|April 20, 2005
Huntington's disease like-2: review and updateRussell L Margolis, Dobrila D Rudnicki, Susan E Holmes
Human Molecular Genetics|June 16, 2011
A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expressionDaniel W Chung, Dobrila D Rudnicki, Lan Yu, et al.
Frontiers in Robotics and AI|January 27, 2021
Exploring Novel Biologically-Relevant Chemical Space Through Artificial Intelligence: The NCATS ASPIRE ProgramKatharine K Duncan, Dobrila D Rudnicki, Christopher P Austin, et al.
Journal of Neuropathology and Experimental Neurology|April 2, 2008
A comparison of huntington disease and huntington disease-like 2 neuropathologyDobrila D Rudnicki, Olga Pletnikova, Jean-Paul G Vonsattel, et al.
Annals of Neurology|March 28, 2007
Huntington's disease--like 2 is associated with CUG repeat-containing RNA fociDobrila D Rudnicki, Susan E Holmes, Mark W Lin, et al.
Disease Models & Mechanisms|February 4, 2016
Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and DrosophilaQian Zhang, Ho Tsoi, Shaohong Peng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 12, 2017
Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's DiseaseDavid G Anderson, Sergio Carmona, Kubendran Naidoo, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Pageof 3